T1	Condition 0 21	Chronic HCV Infection
T2	Qualifier 27 37	Genotype 2
T3	Qualifier 27 35;41 42	Genotype 3
*	OR T2 T3
T4	Scope 27 42	Genotype 2 or 3
R1	Has_scope Arg1:T1 Arg2:T4	
T5	Drug 44 54	Amiodarone
T6	Temporal 133 179	at least 60 days prior to day 1 of SOF/LDV FDC
T7	Reference_point 159 179	day 1 of SOF/LDV FDC
R2	Has_index Arg1:T6 Arg2:T7	
T8	Non-query-able 56 132	Subjects previously treated with amiodarone must have stopped the amiodarone
R3	Has_temporal Arg1:T5 Arg2:T6	
T9	Drug 181 194	Carbamazepine
T10	Drug 196 205	phenytoin
T11	Drug 207 220	phenobarbital
T12	Drug 222 235	oxcarbazepine
*	OR T9 T10 T11 T12
T13	Drug 237 246	Rifabutin
T14	Drug 248 256	rifampin
T15	Drug 260 271	rifapentine
*	OR T13 T14 T15
T16	Non-query-able 273 285	HIV regimens
T17	Drug 297 306	tenofovir
T18	Drug 310 330	tipranavir/ritonavir
*	OR T17 T18
T19	Condition 332 347	St. John's wort
T20	Drug 349 361	Rosuvastatin
T21	Subjective_judgement 363 529	Have any serious or active medical or psychiatric illness which, in the opinion of the investigator, would interfere with subject treatment, assessment, or compliance
T22	Condition 542 564	hepatic encephalopathy
T23	Condition 568 587	variceal hemorrhage
*	OR T22 T23
T24	Measurement 589 616	Hepatitis B surface antigen
T25	Value 617 625	positive
R4	Has_value Arg1:T24 Arg2:T25	
T26	Measurement 627 637	Hemoglobin
T27	Measurement 639 641	Hb
T28	Value 643 651	< 8 g/dL
R5	Subsumes Arg1:T26 Arg2:T27	
R6	Has_value Arg1:T26 Arg2:T28	
T29	Measurement 653 662	Platelets
T30	Value 663 675	= 50,000/mm3
R7	Has_value Arg1:T29 Arg2:T30	
T31	Measurement 677 701	alanine aminotransferase
T32	Measurement 703 706	ALT
T33	Measurement 709 735	aspartase aminotransferase
T34	Measurement 737 740	AST
T35	Measurement 746 766	alkaline phosphatase
T36	Value 767 799	= 10 times upper limit of normal
T37	Scope 677 766	alanine aminotransferase (ALT), aspartase aminotransferase (AST), or alkaline phosphatase
R8	Subsumes Arg1:T31 Arg2:T32	
R9	Subsumes Arg1:T33 Arg2:T34	
*	OR T31 T33 T35
R10	Has_value Arg1:T37 Arg2:T36	
T38	Measurement 806 821	Total bilirubin
T39	Value 822 831	> 3 mg/dl
R11	Has_value Arg1:T38 Arg2:T39	
T40	Condition 840 856	renal impairment
T41	Qualifier 833 839	Severe
R12	Has_qualifier Arg1:T40 Arg2:T41	
T42	Measurement 857 877	creatinine clearance
T43	Measurement 879 883	CrCl
R13	AND Arg1:T42 Arg2:T43	
T44	Value 891 902	< 30 mL/min
R14	Has_value Arg1:T42 Arg2:T44	
T45	Condition 916 943	major organ transplantation
T46	Qualifier 952 977	existing functional graft
R15	Has_qualifier Arg1:T45 Arg2:T46	
T47	Condition 1014 1026	drug allergy
T48	Qualifier 991 1013	clinically-significant
R16	Has_qualifier Arg1:T47 Arg2:T48	
T49	Drug 1030 1040	nucleoside
T50	Drug 1041 1059	nucleotide analogs
*	OR T49 T50
T51	Scope 1030 1059	nucleoside/nucleotide analogs
R17	Has_scope Arg1:T47 Arg2:T51	
T52	Pregnancy_considerations 1062 1113	Pregnant women or women planning to become pregnant
T53	Pregnancy_considerations 1115 1142	Women who are breastfeeding
T54	Observation 1191 1204	alcohol abuse
T55	Observation 1183 1187;1199 1204	drug abuse
*	OR T54 T55
T56	Temporal 1170 1178	= 1 year
T57	Scope 1183 1204	drug or alcohol abuse
R18	Has_temporal Arg1:T57 Arg2:T56	
